miraDry achieves significant growth and recognizes top service providers in North America.

  • miraDry outperforms the aesthetic energy-based device market
  • Recognizes leading service providers across North America
  • Significant growth anticipated for 2025

miraDry has reported substantial growth for 2025, exceeding the overall performance of the aesthetic energy-based device market. This promising development highlights the increased demand for effective solutions in skin and body treatments. The rise in consumer interest showcases the potential of innovative technologies in the beauty sector.

As part of this growth, miraDry is set to acknowledge top service providers across North America who have excelled in delivering its offerings. This recognition aims to reward excellence within the industry and encourage further advancements in aesthetic treatments. The focus remains on providing high-quality results that meet consumer expectations.

The company emphasizes that its success is attributed to a commitment to innovation and superior customer service. The trends observed in the aesthetic energy-based device category suggest a broader acceptance and enthusiasm for non-invasive treatment options, positioning miraDry at the forefront of this evolving market.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

Services PMI at 53.8 in January 2026, According to ISM Report

January sees strong growth in services sector as PMI remains robust. Services…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…